We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-1.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24B
AUM Growth
$0
Cap. Flow
-$3.42M
Cap. Flow %
-0.01%
Top 10 Hldgs %
15.39%
Holding
2,661
New
–
Increased
–
Reduced
9
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.05M
2
FISV
Fiserv Inc
FISV
+$646K
3
BF.B icon
Brown-Forman Class B
BF.B
+$479K
4
BF.A icon
Brown-Forman Class A
BF.A
+$84.1K
5
NEOG icon
Neogen
NEOG
+$73.5K

Sector Composition

Rank Sector Weight
1 Technology 16.3%
2 Healthcare 16.1%
3 Financials 12.91%
4 Industrials 10.68%
5 Consumer Discretionary 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
301
Berkshire Hathaway Class A
BRK.A
$1.07T
$18.7M 0.08%
63
– –
RPM icon
302
RPM International
RPM
$13.8B
$18.6M 0.08%
354,286
– –
GLW icon
303
Corning
GLW
$123B
$18.3M 0.08%
570,783
– –
CRI icon
304
Carter's
CRI
$1.43B
$18.2M 0.08%
154,724
– –
CAT icon
305
Caterpillar
CAT
$402B
$17.8M 0.07%
112,823
– –
BRX icon
306
Brixmor Property Group
BRX
$9.93B
$17.6M 0.07%
942,899
– –
VTI icon
307
Vanguard Total Stock Market ETF
VTI
$655B
$16.9M 0.07%
123,349
– –
FNSR
308
DELISTED
Finisar Corp
FNSR
$16.8M 0.07%
825,578
– –
EW icon
309
Edwards Lifesciences
EW
$47.8B
$16.2M 0.07%
430,431
– –
IT icon
310
Gartner
IT
$9.87B
$16.2M 0.07%
131,294
– –
BGS icon
311
B&G Foods
BGS
$291M
$15.8M 0.07%
449,941
– –
K
312
DELISTED
Kellanova
K
$15.7M 0.07%
245,737
– –
HSY icon
313
Hershey
HSY
$36.6B
$15.7M 0.07%
138,111
– –
BCR
314
DELISTED
CR Bard Inc.
BCR
$15.7M 0.07%
47,263
– –
CPB icon
315
Campbell Soup
CPB
$6.67B
$15.6M 0.06%
323,825
– –
NVO
316
Novo Nordisk
NVO
$220B
$15.4M 0.06%
573,340
– –
YUM icon
317
Yum! Brands
YUM
$40.7B
$15.2M 0.06%
185,736
– –
DGX icon
318
Quest Diagnostics
DGX
$25.6B
$14.9M 0.06%
151,280
– –
ATVI
319
DELISTED
Activision Blizzard
ATVI
$14.4M 0.06%
227,513
– –
VBR icon
320
Vanguard Small-Cap Value ETF
VBR
$37.3B
$14.4M 0.06%
108,243
– –
AZN icon
321
AstraZeneca
AZN
$263B
$14.3M 0.06%
206,227
– –
RSG icon
322
Republic Services
RSG
$66.7B
$14.2M 0.06%
210,423
– –
SNA icon
323
Snap-on
SNA
$21.1B
$14M 0.06%
80,071
– –
DXC icon
324
DXC Technology
DXC
$1.68B
$13.8M 0.06%
168,714
– –
EPD icon
325
Enterprise Products Partners
EPD
$82.5B
$13.7M 0.06%
515,087
– –
11 12
13
14 15

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2018 Portfolio in Review

As of Q1 2018, Glenmede Trust held 2,661 positions worth $24B, unchanged from the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 2,661-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, unchanged from a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's biggest Q1 2018 reduction was Aflac, cutting an estimated $2.05M.
  • Glenmede Trust's ten largest holdings make up 15% of its $24B portfolio in Q1 2018.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2018.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $24B.

Based on Glenmede Trust's 13F filing for Q1 2018, filed 15 May 2018.